Ozanimod Clinical Trials

4 actively recruiting trials across 3 locations

▲ +2 trials since July 2026

Also known as: Zeposia

Pipeline

Phase 2: 1Phase 3: 1Phase 4: 1

Top Sponsors

Bristol-Myers Squibb2
University of Colorado, Denver1
ChenXiaoChun1

Indications

Multiple Sclerosis3
Progressive Multifocal Leukoencephalopathy1
Relapsing Multiple Sclerosis1
Multiple Sclerosis, Relapsing-Remitting1
Alzheimer's Disease1

Other1 trial

Ozanimod in Patients With Alzheimer's Disease

Phase 2

Loma Linda, California1 trial

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Local Institution - 0114

Phase 3

Aurora, Colorado1 trial

Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

University of Colorado Anschutz Medical Campus

Phase 4

Lawrenceville, New Jersey1 trial

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

Bristol Myers Squibb

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.